| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.19B | +3.4% |
| Cost of Revenue | $2.09B | -1.5% |
| Gross Profit | $3.10B | +7.0% |
| R&D Expense | $253.0M | +12.4% |
| SG&A Expense | $1.64B | +7.0% |
| Operating Income | $1.21B | +6.0% |
| Pre-tax Income | $1.09B | -0.9% |
| Income Tax | $253.0M | -1.6% |
| Net Income | $833.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.10B | +44.5% |
| Accounts Receivable | $812.0M | -1.7% |
| Inventory | $288.0M | -3.0% |
| Current Assets | $2.39B | +15.1% |
| Total Assets | $6.41B | +12.5% |
| Current Liabilities | $1.25B | -1.6% |
| Long-term Debt | $2.60B | -1.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $875.0M | -9.1% |
| Capital Expenditures | $55.0M | +1.9% |
| Investing Cash Flow | -$434.0M | -689.1% |
| Financing Cash Flow | -$65.0M | +51.9% |
| Free Cash Flow | $820.0M | -9.8% |
| -0.7% |
| EPS (Basic) | $3.37 | -1.2% |
| EPS (Diluted) | $3.34 | -1.8% |
| Stockholders' Equity |
| $2.04B |
| +47.4% |